Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Treasury Shares (2021 - 2024)

Historic Treasury Shares for RxSight (RXST) over the last 4 years, with Q4 2024 value amounting to $585458.0.

  • RxSight's Treasury Shares fell 997.9% to $585458.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $585458.0, marking a year-over-year decrease of 997.9%. This contributed to the annual value of $585458.0 for FY2024, which is 997.9% down from last year.
  • As of Q4 2024, RxSight's Treasury Shares stood at $585458.0, which was down 997.9% from $650357.0 recorded in Q4 2023.
  • RxSight's 5-year Treasury Shares high stood at $650357.0 for Q4 2023, and its period low was $492862.0 during Q4 2022.
  • In the last 4 years, RxSight's Treasury Shares had a median value of $612968.5 in 2021 and averaged $592289.0.
  • Its Treasury Shares has fluctuated over the past 5 years, first crashed by 2304.79% in 2022, then surged by 3195.52% in 2023.
  • Quarter analysis of 4 years shows RxSight's Treasury Shares stood at $640479.0 in 2021, then dropped by 23.05% to $492862.0 in 2022, then skyrocketed by 31.96% to $650357.0 in 2023, then dropped by 9.98% to $585458.0 in 2024.
  • Its Treasury Shares stands at $585458.0 for Q4 2024, versus $650357.0 for Q4 2023 and $492862.0 for Q4 2022.